3D Tissue Bioprinting

About 90 percent of potential new drugs fail in clinical trials because they are not effective or they cause unexpected toxic effects. This failure happens in large part because the cell-based laboratory tests, called in vitro assays, and animal models used during the drug discovery and development process are too simplistic and do not accurately predict what will happen when the drug is given to humans. Read more…